2021
Sana, S., Reddy, S., Reddy, S., Tokala, R., Kumar, R., Bhargava, S., & Shankaraiah, N. (2021). Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. 110. https://doi.org/10.1016/j.bioorg.2021.104765
AlRawashdh, N., Persky, D., McBride, A., Sweasy, J., Erstad, B., & Abraham, I. (2021). Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival Curves. 21(11). https://doi.org/10.1016/j.clml.2021.06.010
Acosta, M., Muralidhran, P., Abrahamson, M., Grijalva, C., Carver, M., Tang, H., Klinger, C., Fineman, J., Black, S., & Mansour, H. (2021). Comparison of L-Carnitine and L-Carnitine HCL Salt for Targeted Lung Treatment of Pulmonary Hypertension (PH) as Inhalation Aerosols: Design, Comprehensive Characterization, In Vitro 2D/3D Cell Cultures, and In Vivo MCT-Rat Model of PH. https://doi.org/10.1016/j.pupt.2021.101998
Algotar, A., Hsu, C., Chow, H.-H., Dougherty, S., Babiker, H., Marrero, D., Abraham, I., Kumar, R., Ligibel, J., Courneya, K., Smith, T., Jones, B., Lopez, J., Niemiro, G., Ramakumar, S., Hoy, R., Mack, C., & Thomson, C. (2021). Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer. 24(3). https://doi.org/10.1038/s41391-021-00346-z
Le, D., Paulk, I., Axon, D., & Bingham, J. (2021). Comprehensive Medication Review Completion in Medically Underserved Areas and Populations. 32(3). https://doi.org/10.1353/hpu.2021.0133
McBride, A., Macdonald, K., Fuentes-Alburo, A., & Abraham, I. (2021). Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatment. 24(1). https://doi.org/10.1080/13696998.2021.1916863
Macdonald, K., AlRawashdh, N., McBride, A., & Abraham, I. (2021). Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. 17(33). https://doi.org/10.2217/fon-2021-0718
McBride, A., Macdonald, K., & Abraham, I. (2021). Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma. 106. https://doi.org/10.1016/j.leukres.2021.106591
Akinbami, L., Petersen, L., Sami, S., Vuong, N., Lukacs, S., Mackey, L., Atas, J., & LaFleur, B. (2021). Coronavirus Disease 2019 Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Positivity in a Large Survey of First Responders and Healthcare Personnel, May-July 2020. 73(3). https://doi.org/10.1093/cid/ciab080
McBride, A., Macdonald, K., Fuentes-Alburo, A., & Abraham, I. (2021). Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer. 24(1). https://doi.org/10.1080/13696998.2021.1928515
Xu, Y.- ming, Madasu, C., Liu, P., Wijeratne, E., Dierig, D., White, L., Molnár, I., & Gunatilaka, A. (2021). Cycloartane- and Lanostane-Type Triterpenoids from the Resin of Parthenium argentatum AZ-2, a Byproduct of Guayule Rubber Production. 6(23).
Muralidharan, P., Acosta, M., Gomez, A., Grijalva, C., Tang, H., Yuan, J., & Mansour, H. (2021). Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy. 10(3). https://doi.org/10.3390/antiox10030427
Sutar, Y., Fulton, S., Paul, S., Altamirano, S., Mhatre, S., Saeed, H., Patel, P., Mallick, S., Bhat, R., Patravale, V., Chauhan, D., Nielsen, K., & Date, A. (2021). Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and Activity against . 7(9). https://doi.org/10.1021/acsinfecdis.1c00063
McQuade, B., & Campbell, P. (2021). Drug Prescribing: Drug-Drug Interactions. 508.
McQuade, B., & Campbell, P. (2021). Drug Prescribing: Polypharmacy and Deprescribing. 508.
Mohzari, Y., Alshuraim, R., Asdaq, S., Aljobair, F., Alrashed, A., Alsowaida, Y., Alamer, A., Munjem, M., Musawa, M., Hatata, M., Alzaaqi, M., Binrokan, A., Alajlan, S., Abraham, I., & Alamer, A. (2021). Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. 15(1). https://doi.org/10.1016/j.jiph.2021.11.006
Alamer, A., Alrashed, A., Alfaifi, M., Alosaimi, B., AlHassar, F., Almutairi, A., Howaidi, J., Almutairi, A., Mohzari, Y., Sulaiman, T., Al-Jedai, A., Alajami, H., Alkharji, F., Alsaeed, A., Alali, A., Baredhwan, A., Abraham, I., & Almulhim, A. (2021). Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. 37(7). https://doi.org/10.1080/03007995.2021.1920900
Grace, K., Larriva, M., Steiner, H., Marupuru, S., Campbell, P., Patterson, H., Cropp, C., Quinn, D., Klimecki, W., Nix, D., Warholak, T., & Karnes, J. (2021). Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: A nonblinded, randomized controlled trial. 14(6). https://doi.org/10.1111/cts.13121
Chinthammit, C., Axon, D., Mollon, L., Taylor, A., Pickering, M., Black, S., Warholak, T., & Campbell, P. (2021). Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study. 27(1). https://doi.org/10.18553/jmcp.2021.27.1.064
Marupuru, S., Dhatt, H., Bingham, J., & Warholak, T. (2021). Evaluation of a Novel Pharmacist-Delivered Adherence Improvement Service via Telehealth. 9(3). https://doi.org/10.3390/pharmacy9030140
Alkhatib, N., Sweitzer, N., Lee, J., Erstad, B., Slack, M., Gharaibeh, M., Karnes, J., Klimecki, W., Ramos, K., & Abraham, I. (2021). Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure. 21(2). https://doi.org/10.1007/s40256-020-00425-x
Lott, B., Anderson, E., Zapata, L., Cooley, J., Forbes, S., Taylor, A., Manygoats, T., & Warholak, T. (2021). Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice. 61(2). https://doi.org/10.1016/j.japh.2020.11.024
Ray, A.-M., Salim, N., Stevens, M., Chitre, S., Abdeen, S., Washburn, A., Sivinski, J., O’Hagan, H., Chapman, E., & Johnson, M. (2021). Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. 40. https://doi.org/10.1016/j.bmc.2021.116129